Ernesto Freire

USPTO Granted Patents = 16 (Patent Applications = 6)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 59(Granted Patents)

Location History:

Baltimore, MD (US) (1998 - 2017)
North Bethesda, MD (US) (2017)

Company Filing History:

11 out of 3,688

Johns Hopkins University

Fulcrum Pharmaceuticals Inc.

patent

4. 1 out of 2,623

University of Pennsylvania

patents

5. 1 out of 1,210

Dana-Farber-Cancer Institute Inc.

9. 1 out of 832,912

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2017

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9776963 - Small molecule CD4 mimetics and uses thereof (2017-10-03),

2. 9730913 - High affinity beta lactamase inhibitors (2017-08-15),

3. 9606061 - System and method for pH formulations (2017-03-28),

4. 9403763 - CD4-mimetic inhibitors of HIV-1 entry and methods of use thereof (2016-08-02),

5. 9371307 - Serine protease inhibitors (2016-06-21),

6. 9029163 - Method for generation of automated denaturation graphs (2015-05-12),

7. 8859295 - System and method to measure dissociation constants (2014-10-14),

8. 8609040 - System for creation of formulations and generation of denaturation graphs (2013-12-17),

9. 7560482 - Inhibitors of plasmepsins (2009-07-14),

10. 7183267 - β-lactamase inhibitors and methods of use thereof (2007-02-27),

11. 6823267 - Structural prediction of allosterism (2004-11-23),

12. 6772073 - Method for prediction of binding targets and the design of ligands (2004-08-03),

13. 6242190 - Method for high throughput thermodynamic screening of ligands (2001-06-05),

14. 6226603 - Method for the prediction of binding targets and the design of ligands (2001-05-01),

15. 5779363 - Capillary calorimetric cell and method of manufacturing same (1998-07-14),

Title: Celebrating the Innovations of Inventor Ernesto Freire

Introduction: Ernesto Freire, based in Baltimore, MD, is a distinguished inventor known for his significant contributions to the field of biochemistry and medicinal chemistry. With a remarkable portfolio of 16 patents, he has pioneered innovations that address critical needs in medical science and bacterial treatment.

Latest Patents: Among his latest achievements, Freire's invention of small molecule CD4 mimetics stands out. This groundbreaking invention offers a range of compounds that showcase potential therapeutic uses by targeting critical cellular interactions. His other recent patent focuses on high-affinity beta-lactamase inhibitors, which are vital in combatting bacterial infections caused by resistant strains. These patents highlight his commitment to developing effective solutions in the realm of medicine.

Career Highlights: Freire has held key positions in reputable organizations, most notably at The Johns Hopkins University and Avia Biosystems, LLC. His work at these institutions has furthered research and innovations in fields related to health and pharmacology. His contributions have not only advanced scientific understanding but also led to practical applications that benefit society.

Collaborations: Throughout his career, Ernesto has collaborated with other talented professionals, including Richard Brown and Burleigh Hutchins. These partnerships have enabled him to enhance his research and develop more comprehensive approaches to tackling complex scientific challenges.

Conclusion: Ernesto Freire's innovative spirit and dedication to advancing medical science through his inventions continue to make an impact in the field. His work exemplifies how creativity and collaboration can lead to meaningful advancements, paving the way for future breakthroughs in medicine and beyond.

This text is generated by artificial intelligence and may not be accurate.